Víctor Fernández-Dueñas

Affiliations: 
2007-2023 Department of Pathology and Experimental Therapeutics Universitat de Barcelona, Barcelona, Cataluña, Spain 
Google:
"Víctor Fernández-Dueñas"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Taura J, López-Cano M, Fernández-Dueñas V, et al. (2023) Visualizing G Protein-Coupled Receptor-Receptor Interactions in Brain Using Proximity Ligation In Situ Assay. Current Protocols. 3: e794
Morató X, Fernández-Dueñas V, Pérez-Villamor P, et al. (2023) Development of a Novel σ Receptor Biosensor Based on Its Heterodimerization with Binding Immunoglobulin Protein in Living Cells. Acs Chemical Neuroscience
Prieto-Díaz R, González-Gómez M, Fojo-Carballo H, et al. (2022) Exploring the Effect of Halogenation in a Series of Potent and Selective A Adenosine Receptor Antagonists. Journal of Medicinal Chemistry
Crans RAJ, Wouters E, Valle-León M, et al. (2022) Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders. Frontiers in Pharmacology. 13: 1075433
Sarasola LI, Del Torrent CL, Pérez-Arévalo A, et al. (2022) The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A-A receptor heteromer formation and function. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 156: 113896
Fernández-Dueñas V, Bonaventura J, Aso E, et al. (2021) Overcoming the challenges of detecting gpcr oligomerization in the brain. Current Neuropharmacology
Hüll K, Fernández-Dueñas V, Schönberger M, et al. (2021) Optical Control of Adenosine-Mediated Pain Modulation. Bioconjugate Chemistry
López-Cano M, Font J, Aso E, et al. (2021) Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects. British Journal of Pharmacology
Morató X, Garcia-Esparcia P, Argerich J, et al. (2021) Ecto-GPR37: a potential biomarker for Parkinson's disease. Translational Neurodegeneration. 10: 8
Valle-León M, Callado LF, Aso E, et al. (2020) Decreased striatal adenosine A-dopamine D receptor heteromerization in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
See more...